Hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy is unaltered by long-term oral L-arginine administration

Vascular Pharmacology

Volumn 49, Issue 2-3, 2008, Pages 71-76

  Laursen, Britt Elmedal ^a   Dam, Mette Y ^a   Mulvany, Michael J ^a   Simonsen, Ulf ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Chronic hypoxic pulmonary hypertension; L arginine; Pulmonary resistance arteries; Right ventricular hypertrophy

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ARGININE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; THROMBOXANE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; HEART MUSCLE RELAXATION; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; TREATMENT RESPONSE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; ANOXIA; ARGININE; BLOOD PRESSURE; CHRONIC DISEASE; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; MALE; NITRIC OXIDE; ORGAN SIZE; OXYGEN; PENICILLAMINE; PULMONARY ARTERY; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 50849135887     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2008.03.001     Document Type: Article

References (37)

1. Andersen C.U., Mulvany M.J., and Simonsen U. Lack of synergistic effect of molsidomine and sildenafil on development of pulmonary hypertension in chronic hypoxic rats. Eur. J. Pharmacol. 510 (2005) 87-96
2. Block E.R., Herrera H., and Couch M. Hypoxia inhibits L-arginine uptake by pulmonary artery endothelial cells. Am. J. Physiol. 269 (1995) L574-L580
3. Carville C., Raffestin B., Eddahibi S., Blouquit Y., and Adnot S. Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J. Cardiovasc. Pharmacol. 22 (1993) 889-896
4. Durante W., Johnson F.K., and Johnson R.A. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin. Exp. Pharmacol. Physiol. 34 9 (2007) 906-911
5. Eddahibi S., Adnot S., Carville C., Blouquit Y., and Raffestin B. L-arginine restores endothelium-dependent relaxation in pulmonary circulation of chronically hypoxic rats. Am. J. Physiol. 263 (1992) L194-L200
6. Elmedal B., de Dam M.Y., Mulvany M.J., and Simonsen U. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. Br. J. Pharmacol. 141 (2004) 105-113
7. Emery C.J. Vasodilator action of S-nitrosothiol, SNAP, in rat isolated perfused lung. Physiol. Res. 44 1 (1995) 19-24
8. Fagan J.M., Rex S.E., Hayes-Licitra S.A., and Waxman L. L-arginine reduces right heart hypertrophy in hypoxia-induced pulmonary hypertension. Biochem. Biophys. Res. Commun. 254 (1999) 100-103
9. Fike C.D., Kaplowitz M.R., Rehorst-Paea L.A., and Nelin L.D. L-arginine increases nitric oxide production in isolated lungs of chronically hypoxic newborn pigs. J. Appl. Physiol. 88 (2000) 1797-1803
10. Giugliano D., Marfella R., Verrazzo G., Acampora R., Coppola L., Cozzolino D., and Donofrio F. The vascular effects of L-arginine in humans - the role of endogenous insulin. J. Clin. Invest. 99 (1997) 433-438
11. Hampl V., and Herget J. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol. Rev. 80 (2000) 1337-1372
12. Hasuda T., Satoh T., Shimouchi A., Sakamaki F., Kyotani S., Matsumoto T., Goto Y., and Nakanishi N. Improvement in exercise capacity with nitric oxide inhalation in patients with precapillary pulmonary hypertension. Circulation 101 (2000) 2066-2070
13. Hobbs A.J., Higgs A., and Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Ann. Rev. Pharmacol. Toxicol. 39 (1999) 191-220
14. Hucks D., Khan N.M., and Ward J.P.T. Essential role of L-arginine uptake and protein tyrosine kinase activity for NO-dependent vasorelaxation induced by stretch, isometric tension and cyclic AMP in rat pulmonary arteries. Br. J. Pharmacol. 131 (2000) 1475-1481
15. Jernigan N.L., Resta T.C., and Walker B.R. Contribution of oxygen radicals to altered NO-dependent pulmonary vasodilation in acute and chronic hypoxia. Am. J. Physiol. Lung. Cell. Mol. Physiol. 286 (2004) L947-L955
16. Jiang B.H., Maruyama J., Yokochi A., Iwasaki A., Amano H., Mitani Y., and Maruyama K. Prolonged nitric oxide inhalation fails to regress hypoxic vascular remodeling in rat lung. Chest 125 (2004) 2247-2252
17. Lass A., Suessenbacher A., Wolkart G., Mayer B., and Brunner F. Functional and analytical evidence for scavenging of oxygen radicals by L-arginine. Mol. Pharmacol. 61 (2002) 1081-1088
18. Martinez, A.C., Stankevicius, E., Jakobsen, P.J., Simonsen, U., in press. Blunted vasodilatatory neurotransmission in penile arteries from renal hypertensive rats. Vascl. Pharmacol.
19. Mehta S., Stewart D.J., Langleben D., and Levy R.D. Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation 92 (1995) 1539-1545
20. Mingone C.J., Gupte S.A., Iesaki T., and Wolin M.S. Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries. Am. J. Physiol. Lung. Cell. Mol. Physiol. 285 (2003) L296-L304
21. Mitani Y., Maruyama K., and Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96 (1997) 689-697
22. Movahed P., Högestätt E.D., and Petersson J. Effect of hypoxia on vasodilator responses to S-nitroso-N-acetylpenicillamine and levcromakalim in guinea pig basilar artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 367 (2003) 532-537
23. Mulvany M.J., and Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41 (1977) 19-26
24. Nagaya N., Uematsu M., Oya H., Sato N., Sakamaki F., Kyotani S., Ueno K., Nakanishi N., Yamagishi M., and Miyatake K. Short-term oval administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 163 (2001) 887-891
25. Palmer R.M.J., Ferrige A.G., and Moncada S. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
26. Pepke-Zaba J., Higenbottam T.W., Dinh-Xuan A.T., Stone D., and Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338 (1991) 1173-1174
27. Quyyumi A.A. Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral d- and L-arginine. J. Am. Coll. Cardiol. 32 (1998) 904-911
28. Resta T.C., and Walker B.R. Orally administered L-arginine does not alter right ventricular hypertrophy in chronically hypoxic rats. Am. J. Physiol. 266 (1994) R559-R563
29. Roberts J.D., Roberts C.T., Jones R.C., Zapol W.M., and Bloch K.D. Continuous nitric-oxide inhalation reduces pulmonary arterial structural-changes, right-ventricular hypertrophy, and growth-retardation in the hypoxic newborn rat. Circ. Res. 76 (1995) 215-222
30. Roberts J.D., Chiche J.D., Weimann J., Steudel W., Zapol W.M., and Bloch K.D. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ. Res. 87 (2000) 140-145
31. Rossaint R., Pison U., Gerlach H., and Falke K.J. Inhaled nitric-oxide - its effects on pulmonary circulation and airway smooth-muscle cells. Eur. Heart J. 14 (1993) 133-140
32. Sasaki S., Asano M., Ukai T., Nomura N., Maruyama K., Manabe T., and Mishima A. Nitric oxide formation and plasma L-arginine levels in pulmonary hypertensive rats. Respir. Med. 98 (2004) 205-212
33. Su Y.C., and Block E.R. Hypoxia inhibits L-arginine synthesis from L-citrulline in porcine pulmonary-artery endothelial-cells. Am. J. Physiol. 13 (1995) L581-L587
34. van Suylen R.J., Smits J.F., and Daemen M.J. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am. J. Respir. Crit Care Med. 157 (1998) 1423-1428
35. Wu G., and Meininger C.J. Arginine nutrition and cardiovascular function. J. Nutr. 130 (2000) 2626-2629
36. Zapol W.M., Falke K.J., Hurford W.E., and Roberts J.D. Inhaling nitric-oxide - a selective pulmonary vasodilator and bronchodilator. Chest 105 (1994) S87-S91
37. Zharikov S.I., and Block E.R. Association of L-arginine transporters with fodrin: implications for hypoxic inhibition of arginine uptake. Am. J. Physiol. 278 (2000) L111-L117